Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Masellis

Showing results (291-300 of 337) with videos related to

Pageof 34
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 18, 2023
Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: Results from the Ontario Neurodegenerative Disease Research InitiativeErlan Sanchez, Tim Wilkinson, Gillian Coughlan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 11, 2020
Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementiaEmma L van der Ende, Meifang Xiao, Desheng Xu, et al.
Brain : a Journal of Neurology|October 23, 2021
SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degenerationMathieu Barbier, Agnès Camuzat, Khalid El Hachimi, et al.
European Journal of Neurology|January 24, 2023
White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research InitiativeDaniela Cristina Carvalho de Abreu, Frederico Pieruccini-Faria, Yanina Sarquis-Adamson, et al.
International Journal of Geriatric Psychiatry|May 28, 2022
Caregiving concerns and clinical characteristics across neurodegenerative and cerebrovascular disorders in the Ontario neurodegenerative disease research initiativeDerek Beaton, Paula M McLaughlin, Joseph B Orange, et al.
Brain Communications|November 17, 2025
Thalamus involvement in genetic frontotemporal dementia assessed using structural and diffusion MRI: a GENFI studySonja Soskic, Henry F J Tregidgo, Emily G Todd, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 5, 2023
Rare neurovascular genetic and imaging markers across neurodegenerative diseasesAllison A Dilliott, Stephanie A Berberian, Kelly M Sunderland, et al.
Journal of Neuroinflammation|September 5, 2022
Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI studyEmma L van der Ende, Carolin Heller, Aitana Sogorb-Esteve, et al.
Neurobiology of Aging|May 27, 2021
Association of apolipoprotein E variation with cognitive impairment across multiple neurodegenerative diagnosesAllison A Dilliott, Kelly M Sunderland, Paula M McLaughlin, et al.
Alzheimer'S Research & Therapy|January 12, 2024
Diagnostic accuracy of research criteria for prodromal frontotemporal dementiaAlberto Benussi, Enrico Premi, Mario Grassi, et al.
Pageof 34

Showing results (291-300 of 337) with videos related to

Sort By:
Pageof 34
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 18, 2023
Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: Results from the Ontario Neurodegenerative Disease Research InitiativeErlan Sanchez, Tim Wilkinson, Gillian Coughlan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 11, 2020
Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementiaEmma L van der Ende, Meifang Xiao, Desheng Xu, et al.
Brain : a Journal of Neurology|October 23, 2021
SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degenerationMathieu Barbier, Agnès Camuzat, Khalid El Hachimi, et al.
European Journal of Neurology|January 24, 2023
White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research InitiativeDaniela Cristina Carvalho de Abreu, Frederico Pieruccini-Faria, Yanina Sarquis-Adamson, et al.
International Journal of Geriatric Psychiatry|May 28, 2022
Caregiving concerns and clinical characteristics across neurodegenerative and cerebrovascular disorders in the Ontario neurodegenerative disease research initiativeDerek Beaton, Paula M McLaughlin, Joseph B Orange, et al.
Brain Communications|November 17, 2025
Thalamus involvement in genetic frontotemporal dementia assessed using structural and diffusion MRI: a GENFI studySonja Soskic, Henry F J Tregidgo, Emily G Todd, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 5, 2023
Rare neurovascular genetic and imaging markers across neurodegenerative diseasesAllison A Dilliott, Stephanie A Berberian, Kelly M Sunderland, et al.
Journal of Neuroinflammation|September 5, 2022
Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI studyEmma L van der Ende, Carolin Heller, Aitana Sogorb-Esteve, et al.
Neurobiology of Aging|May 27, 2021
Association of apolipoprotein E variation with cognitive impairment across multiple neurodegenerative diagnosesAllison A Dilliott, Kelly M Sunderland, Paula M McLaughlin, et al.
Alzheimer'S Research & Therapy|January 12, 2024
Diagnostic accuracy of research criteria for prodromal frontotemporal dementiaAlberto Benussi, Enrico Premi, Mario Grassi, et al.
Pageof 34